Streetbeat News

Stock Prices

ATER

Aterian shares are trading higher following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:43 pm

BLZE

Backblaze shares are trading higher following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:42 pm

LCTX

Lineage Cell Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:42 pm

MAPS

WM Technology shares are trading higher following the release of their Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:41 pm

CTXR

Citius Pharmaceuticals Inc (NASDAQ:CTXR) has received FDA approval for its skin cancer drug Lymphir, a year after an initial rejection. Lymphir is the first FDA-approved product for Citius and targets the interleukin-2 receptor on malignant T-cells and Tregs. The company plans to launch the drug in the U.S. within five months. The approval is based on a phase 3 trial showing a 36% overall response rate. CTXR stock closed lower by 1.76% at $0.88 on Thursday.

Portfolio Pulse from Vandana Singh

August 08, 2024 | 9:41 pm

IDN

Intellicheck shares are trading lower after the company reported worse-than-expected Q2 revenue results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:41 pm

LOGC

ContextLogic (NASDAQ:LOGC) reported Q2 2024 adjusted EPS of $(0.50), missing the $(0.06) estimate by 733.33%. However, sales of $7.00M beat the $1.74M estimate by 302.30%, despite a 91.03% decrease from $78.00M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:41 pm

SYRA

Syra Health shares are trading lower after the company reported worse-than-expected Q2 EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:41 pm

NKTR

Nektar Therapeutics (NASDAQ:NKTR) reported Q2 2024 GAAP EPS of $(0.25), missing the analyst estimate of $(0.21) by 19.05%. However, the company reported sales of $23.489 million, beating the estimate of $17.545 million by 33.88% and showing a 14.59% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:41 pm

TTWO

Take-Two Interactive Software Inc (NASDAQ:TTWO) reported its fiscal first-quarter results, showing a 4% year-over-year increase in revenue to $1.34 billion and a 1% increase in net bookings to $1.22 billion. Despite a net loss of $1.52 per share, the company reiterated its full-year net bookings outlook and provided guidance for the second quarter and full year. The stock jumped 5.35% following the announcement.

Portfolio Pulse from Adam Eckert

August 08, 2024 | 9:40 pm